Yong Lu, PhD

Medicine & Life Sciences

1. Multiple Myeloma 100%
2. Neoplasms 81%
3. Immunotherapy 71%
4. T-Lymphocytes 59%
5. Interleukin-9 46%
6. Immunity 42%
7. Chimeric Antigen Receptors 42%
8. Dendritic Cells 37%
9. Myxoma virus 34%
10. Macrophages 27%
11. Mantle-Cell Lymphoma 25%
12. T-Cell Antigen Receptor 22%
13. Vaccines 22%
14. p38 Mitogen-Activated Protein Kinases 22%
15. Osteoclasts 22%
16. Immunosuppressive Agents 21%
17. Myeloid Cells 20%
18. Immunosuppression 20%
19. Drug Resistance 19%
20. Adoptive Immunotherapy 18%
21. Bone Marrow 18%
22. NVP-BKM120 17%
23. Drug Therapy 16%
24. Triggering Receptor Expressed on Myeloid Cells-1 16%
25. Neoplasm Antigens 16%
26. Experimental Melanomas 15%
27. P-selectin ligand protein 15%
28. Tumor Escape 15%
29. Cell Survival 15%
30. Antigens 15%
31. Colony-Stimulating Factor Receptors 15%
32. Cell- and Tissue-Based Therapy 15%
33. SARS Virus 14%
34. Immune Evasion 14%
35. Regulatory T-Lymphocytes 14%
36. Blocking Antibodies 13%
37. Growth 13%
38. In Vitro Techniques 13%
39. Interferons 13%
40. Apoptosis 13%
41. Monocytes 13%
42. Cell Plasticity 13%
43. RNA-Seq 13%
44. Organoids 13%
45. Selectins 12%
46. Cell Differentiation 12%
47. Hedgehog Proteins 12%
48. Therapeutic Uses 12%
49. Eragrostis 12%
50. CD40 Ligand 12%